Project Grant R01AA032811
- The National Institute on Alcohol Abuse and Alcoholism awarded Children's Research Institute $648,180 on June 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate mechanisms and potential pharmacotherapy of neurocognitive deficits in fetal alcohol spectrum disorders. The research examines the long-term neurobehavioral impact of prenatal alcohol exposure, with focus on apolipoprotein E (APOE) signaling in the motor cortex as a therapeutic target. The project builds on...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Trustees of Columbia University in the City of New York $723,453 on July 10, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct the Prenatal Alcohol Gene-by-Exposure (PAGE) Study, examining the roles of maternal-child genetic profiles in fetal alcohol spectrum disorders. The study will perform whole-genome sequencing on both mothers and children, along with methylomic, transcriptomic, and phenotypic analysis to...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of New Mexico Health Sciences Center $160,744 on March 9, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate electrophysiological mechanisms of prenatal alcohol exposure (PAE) effects on cognitive control. The project combines translational touchscreen testing and in vivo electrophysiology to determine how PAE impairs executive function domains in mouse models. The research hypothesizes that...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Washington $725,022 on August 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct longitudinal and cross-sectional research examining age-related brain changes in adults with fetal alcohol spectrum disorders. The project will follow 60 adults with FASD and 30 healthy comparison adults aged 30–65 years at baseline through a series of neuroimaging and cognitive assessments to characterize brain...
- The National Institute on Alcohol Abuse and Alcoholism awarded Weill Medical College of Cornell University $591,468 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct longitudinal neuroimaging analysis identifying neural risk factors for drinking onset in young adulthood. The recipient will apply machine learning analysis to nine years of longitudinal neuroimaging, behavioral, and neuropsychological data from 466 adolescents (baseline ages 12–18 years) enrolled in...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of North Carolina at Chapel Hill $1,170,144 on September 20, 2025, under the Alcohol Research Programs CFDA 93.273, to conduct a prospective study of fetal alcohol spectrum disorder (FASD) risk assessment integrating maternal alcohol exposure, maternal mental health, and paternal risk factors. The award funds a research phase (R33) that builds on completed preliminary work (R61) to develop and validate a multivariate...
- The National Institute on Alcohol Abuse and Alcoholism, part of the Department of Health and Human Services National Institutes of Health, awarded $177,551 to The Trustees of Columbia University in the City of New York on July 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a K99/R00 Project Grant. The award funds research training and mentorship for Dr. Emilie Bruzelius to investigate how economic stressors mediate prenatal alcohol use and related birth outcomes. In the...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Leland Stanford Junior University $597,138 under the Alcohol Research Programs (CFDA 93.273) on May 1, 2026, for a project grant investigating the neural mechanisms linking alcohol-induced sleep disruption and alcohol use disorder. The research examines how chronic alcohol exposure disrupts sleep through maladaptive changes in the extended amygdala, a brain region that controls sleep and wake states. The project focuses on two...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Medical University of South Carolina $488,077 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate molecular and functional adaptations in the nucleus reuniens, a midline thalamic region implicated in alcohol-related cognitive deficits. The research addresses how chronic alcohol exposure produces cognitive dysfunction that impairs treatment outcomes and increases relapse risk. The project will...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Research Foundation for the State University of New York $493,145 on September 25, 2025, under the Alcohol Research Programs (CFDA 93.273) to examine emotion regulation strategy use in an outpatient treatment program for adolescents with co-occurring alcohol use disorder and psychiatric diagnoses. The research employs ecological momentary assessment (EMA) to study how adolescents aged 13–18 develop and deploy emotion regulation...
The National Institute on Alcohol Abuse and Alcoholism awarded New York University $746,805 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate developmental pathways linking prenatal alcohol exposure to adult externalizing outcomes in adolescents. The research, titled the DREAMS study (Developmental Research on Externalizing Outcomes Among Youth with Prenatal Alcohol Exposure: Mediating Role of Cognitive Control and Sleep), leverages the NIH SAFE PASSAGE and PASS-ECHO cohorts in South Dakota—the largest U.S. prospective pregnancy cohort with daily, timeline follow-back prenatal alcohol exposure data. The study will follow approximately 650 South Dakota adolescents (49 percent with documented prenatal alcohol exposure) from age 16 through age 18 to test pathways from prenatal exposure to youth externalizing outcomes. At age 16, participants will complete 14 days of at-home wearable monitoring to derive objective sleep metrics and electroencephalography and event-related potential assessments of cognitive control. At age 18, participants will complete multi-informant questionnaires and structured clinical interviews to assess dimensional externalizing symptoms and DSM-5 diagnoses. The study will determine how gestational timing and quantity of prenatal alcohol exposure relate to externalizing outcomes, test adolescent sleep health and cognitive-control neurophysiology as mediators of associations, and evaluate family and neighborhood contexts that foster resilience. Place of performance is New York, NY. The award runs through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $746.8k | 8/27/26 |